Updating results

37 results for Apixaban Sort: Relevance | Date

Apixaban for preventing stroke and systemic embolism in people with nonvalvular atrial fibrillation (TA275)

Evidence-based recommendations on apixaban (Eliquis) for preventing stroke and systemic embolism in people with nonvalvular atrial fibrillation (AF)

Technology appraisal guidance Published February 2013

Apixaban for the prevention of venous thromboembolism after total hip or knee replacement in adults (TA245)

Evidence-based recommendations on apixaban (Eliquis) for preventing venous thromboembolism (VTE) after total hip or knee replacement in adults

Technology appraisal guidance Published January 2012

Edoxaban for preventing stroke and systemic embolism in people with non-valvular atrial fibrillation (TA355)

Evidence-based recommendations on edoxaban (Lixiana) for preventing stroke and systemic embolism in people with non-valvular atrial fibrillation (AF)

Technology appraisal guidance Published September 2015

Venous thromboembolism in over 16s: reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism (NG89)

Evidence-based recommendations on assessing and reducing the risk of venous thromboembolism (VTE) and deep vein thrombosis (DVT) in people aged 16 and over

NICE guideline Published March 2018

Venous thromboembolism

Everything NICE has said on assessing, diagnosing, treating and reducing the risk of venous thromboembolism in adults in an interactive flowchart

NICE Pathway Published May 2011 Last updated March 2018

Atrial fibrillation

Everything NICE has said on diagnosing and managing atrial fibrillation in an interactive flowchart

NICE Pathway Published June 2014 Last updated November 2018

KTT16: Anticoagulants, including non-vitamin K antagonist oral anticoagulants (NOACs)

the use of the 4 non-vitamin K antagonist oral anticoagulants (NOACs), apixaban, dabigatran etexilate, edoxaban and rivaroxaban, in...

Key therapeutic topic Published February 2016 Last updated February 2018

Structural heart defects

Everything NICE has said on structural heart defects in an interactive flowchart

NICE Pathway Published November 2013 Last updated August 2018

There is a need for additional research on the management of bleeds that occur while people are receiving apixaban, rivaroxaban or dabigatran etexilate, as there are no antidotes or established treatments to stop active bleeding for these agents.

research on the management of bleeds that occur while people are receiving apixaban, rivaroxaban or dabigatran etexilate, as there are...

Research recommendation Published June 2015

Atrial fibrillation (QS93)

Evidence-based statements to deliver quality improvements in the identification, treatment and management of atrial fibrillation (AF) in adults

Quality standard Published July 2015 Last updated February 2018

Block scoping reports

NICE block scoping reports

Published January 2019

Static list

NICE technology appraisal guidance static list

Published January 2018

Venous thromboembolism - apixaban (acute medical illness) [ID310]

In development [GID-TAG419] Expected publication date: TBC

Technology appraisal guidance In development

Indicator Advisory Committee members

2015, as Deputy CEO. Jo has sat on NICE STAs and Scoping workshops for Apixaban, Dabigatran, Dronedarone, Rivaroxaban and Vernakalent...

Published July 2018

ESNM73: Reversal of the anticoagulant effect of dabigatran: idarucizumab

Summary of the evidence on idarucizumab for reversing the anticoagulant effect of dabigtatran to inform local NHS planning and decision-making

Evidence summary Published May 2016

Atrial fibrillation and heart valve disease: self-monitoring coagulation status using point-of-care coagulometers (the CoaguChek XS system) (DG14)

Evidence-based recommendations on point-of-care coagulometers (the CoaguChek XS system) to self-monitor blood clotting

Diagnostics guidance Published September 2014 Last updated December 2017

Chronic kidney disease in adults: assessment and management (CG182)

Evidence-based recommendations on the assessment and management of chronic kidney disease (CKD) in adults

Clinical guideline Published July 2014 Last updated January 2015

Rivaroxaban for treating pulmonary embolism and preventing recurrent venous thromboembolism (TA287)

Evidence-based recommendations on rivaroxaban (Xarelto) for treating pulmonary embolism and preventing recurrent venous thromboembolism

Technology appraisal guidance Published June 2013

MIB35: AliveCor Heart Monitor and AliveECG app (Kardia Mobile) for detecting atrial fibrillation

Advice on the use of the AliveCor Heart Monitor and AliveECG (Kardia Mobile) app for detecting atrial fibrillation (AF) to aid local decision-making

Medtech innovation briefing Published August 2015

Research recommendations

TA245/1 | More trials of apixaban compared with other low molecular weight heparin (LMWHs) in total hip and

Published April 2016

New stroke prevention treatment recommended by NICE

Patients with atrial fibrilation can now be offered apixaban (Eliquis) as an alternative to warfarin to reduce the risk of stroke and blood clots, says NICE.

News Published February 2013

Thousands of strokes and deaths preventable from 'silent killer'

Thousands of strokes and deaths due to atrial fibrillation could be prevented each year by ensuring patients receive effective anticoagulant drugs, according to updated guidance from NICE.

News Published June 2014

Offer anticoagulants instead of aspirin for stroke prevention

Adults with atrial fibrillation (AF) should be prescribed newer medications instead of aspirin for the prevention of stroke, says NICE.

News Published July 2015

The NICE year in review – part 1

A quick look at the guidance and advice that has generated the most interest during the first half of the year.

News Published December 2014

Novel oral anticoagulants an option for patients with atrial fibrillation

Offering patients anticoagulants could help prevent thousands of strokes and premature deaths from atrial fibrillation (AF), according to NICE.

News Published June 2014

Exploring the impact of NICE technology appraisals

As NICE publishes its 300th technology appraisal, we look back at the impact they have had on patient care.

News Published November 2013

Improving production times for guidance on new pharmaceuticals

One of NICE?s regular functions is to produce recommendations on the use of new and existing medicines and treatments in the NHS.

News Published March 2013